The new office in China will allow for direct presences in the Chinese market, which will enhance the company’s local capabilities, according to the report. The new branch will initially focus on the neurosurgical business, but the company plans to introduce products from the spine and orthobiologics market as well.
Related Articles on Orthopedic Device Companies:
Mazor Sells Three U.S. Robotic Spine Systems in 3Q, Reports $1.6M in Revenue
Medtronic Launches T2 Altitude Expandable Corpectomy Device
ArthroCare to Settle Private Securities Class Action Suit
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
